Scholarlink

The Coronavirus disease 2019, known as COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 or SARS-CoV-2 infection, first came into notice in December 2019 and was announced as a pandemic by the World Health Organization in March 2020. Despite people spanning all age groups being susceptible to COVID-19, individuals with preexisting diseases are more vulnerable. Due to the immunocompromised condition, cancer patients posed an elevated risk of severity, complications, as well as death in the COVID-19 pandemic. This chapter provides insight into the SARS-CoV-2 infections in cancer patients and related outcomes. Here, we discuss the risk factors linked to COVID-19 and cancer, underlying molecular mechanisms, and the impact of COVID-19 treatments on cancer patients.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

COVID-19 Comorbidities in Cancer

  • 章节

  • 发表日期：

    2025年

查看全文
  • Kritika Prasad,
  • Saurav K. Saha,
  • Sourav Sanyal,
  • Arundhaty Pal,
  • Tapas K. Sengupta

摘要

The Coronavirus disease 2019, known as COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 or SARS-CoV-2 infection, first came into notice in December 2019 and was announced as a pandemic by the World Health Organization in March 2020. Despite people spanning all age groups being susceptible to COVID-19, individuals with preexisting diseases are more vulnerable. Due to the immunocompromised condition, cancer patients posed an elevated risk of severity, complications, as well as death in the COVID-19 pandemic. This chapter provides insight into the SARS-CoV-2 infections in cancer patients and related outcomes. Here, we discuss the risk factors linked to COVID-19 and cancer, underlying molecular mechanisms, and the impact of COVID-19 treatments on cancer patients.